|
DE3164143D1
(en)
|
1980-07-01 |
1984-07-19 |
Nat Res Dev |
Production of viral antigens
|
|
JPS58500366A
(ja)
|
1981-03-06 |
1983-03-10 |
セルテツク リミテツド |
単一クロ−ン抗体
|
|
US4526934A
(en)
*
|
1982-03-19 |
1985-07-02 |
Bridgestone Tire Company Limited |
Branched styrene-butadiene copolymers and pneumatic tires using the same
|
|
DE3378250D1
(en)
|
1982-04-22 |
1988-11-24 |
Ici Plc |
Continuous release formulations
|
|
US5340926A
(en)
|
1983-03-25 |
1994-08-23 |
Celltech, Limited |
Process for the recovery of recombinantly produced protein from insoluble aggregate
|
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
|
US5332805A
(en)
|
1984-02-03 |
1994-07-26 |
Celltech Limited |
Process for the recovery of recombinantly produced chymosin from insoluble aggregate
|
|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
|
FR2590674B1
(fr)
|
1985-11-25 |
1989-03-03 |
Inst Nat Sante Rech Med |
Nouveaux reactifs de diagnostic
|
|
US5149650A
(en)
|
1986-01-14 |
1992-09-22 |
University Of North Carolina At Chapel Hill |
Vaccines for human respiratory virus
|
|
US4659563A
(en)
|
1986-01-27 |
1987-04-21 |
Miles Laboratories, Inc. |
High titer anti-respiratory syncytial virus intravenous immune globulin
|
|
US4717766A
(en)
|
1986-01-27 |
1988-01-05 |
Miles Laboratories, Inc. |
Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
|
|
US5271927A
(en)
|
1986-02-13 |
1993-12-21 |
Celltech Limited |
Antibody conjugates with macrocyclic ligands
|
|
US5468606A
(en)
|
1989-09-18 |
1995-11-21 |
Biostar, Inc. |
Devices for detection of an analyte based upon light interference
|
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
|
US4800078A
(en)
|
1987-05-28 |
1989-01-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
|
|
GB8719041D0
(en)
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
|
GB8720833D0
(en)
|
1987-09-04 |
1987-10-14 |
Celltech Ltd |
Recombinant dna product
|
|
US5223254A
(en)
|
1987-09-29 |
1993-06-29 |
Praxis Biologics, Inc. |
Respiratory syncytial virus: vaccines
|
|
ATE85622T1
(de)
|
1987-12-23 |
1993-02-15 |
Upjohn Co |
Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
|
|
JP3095168B2
(ja)
|
1988-02-05 |
2000-10-03 |
エル． モリソン，シェリー |
ドメイン‐変性不変部を有する抗体
|
|
US5183657A
(en)
|
1988-03-11 |
1993-02-02 |
Celltech Limited |
Antibodies for use in antilymphocyte antibody therapy
|
|
JPH01268646A
(ja)
|
1988-04-20 |
1989-10-26 |
Meiji Milk Prod Co Ltd |
抗腫瘍剤
|
|
US5137804A
(en)
|
1988-05-10 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Assay device and immunoassay
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
JP2919890B2
(ja)
|
1988-11-11 |
1999-07-19 |
メディカル リサーチ カウンスル |
単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5354554A
(en)
|
1989-02-10 |
1994-10-11 |
Celltech Limited |
Crosslinked antibodies and processes for their preparation
|
|
US6093872A
(en)
|
1989-05-05 |
2000-07-25 |
Systemix, Inc. |
Extended human hematopoiesis in a heterologous host
|
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
|
US5332567A
(en)
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
|
US5518725A
(en)
|
1989-09-25 |
1996-05-21 |
University Of Utah Research Foundation |
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
|
|
WO1991005548A1
(en)
|
1989-10-10 |
1991-05-02 |
Pitman-Moore, Inc. |
Sustained release composition for macromolecular proteins
|
|
EP0550436A1
(en)
|
1989-11-06 |
1993-07-14 |
Alkermes Controlled Therapeutics, Inc. |
Protein microspheres and methods of using them
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5279935A
(en)
|
1990-03-01 |
1994-01-18 |
Becton, Dickinson And Company |
Method of immunossay including deactivation of endogenous alkaline phosphatase
|
|
ES2090332T3
(es)
|
1990-05-03 |
1996-10-16 |
Systemix Inc |
Tejido linfoide humano en un hospedador inmunocomprometido.
|
|
GB9020282D0
(en)
|
1990-09-17 |
1990-10-31 |
Gorman Scott D |
Altered antibodies and their preparation
|
|
DE69223955T2
(de)
|
1991-04-22 |
1998-08-13 |
Massachusetts Health Research Institute, Inc. (Mhri), Boston, Mass. |
Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
|
|
ATE221379T1
(de)
|
1991-05-01 |
2002-08-15 |
Jackson H M Found Military Med |
Verfahren zur behandlung infektiöser respiratorischer erkrankungen
|
|
CA2044940A1
(en)
|
1991-06-10 |
1992-12-11 |
Inder M. Verma |
Transdominant negative proto-oncogene
|
|
WO1993005796A1
(en)
|
1991-09-19 |
1993-04-01 |
The Scripps Research Institute |
Method for producing human antibodies in a non-human animal, and animals therefor
|
|
US5240694A
(en)
|
1991-09-23 |
1993-08-31 |
University Of Virginia |
Combined antiviral and antimediator treatment of common colds
|
|
US5418136A
(en)
|
1991-10-01 |
1995-05-23 |
Biostar, Inc. |
Devices for detection of an analyte based upon light interference
|
|
DK0614530T3
(da)
|
1991-11-15 |
1998-09-28 |
Cornell Res Foundation Inc |
Indirekte immunassay for dioxinlignende forbindelser
|
|
US20020102257A1
(en)
|
1998-09-21 |
2002-08-01 |
Leslie Sid Johnson |
Human-murine chimeric antibodies against respiratory syncytial virus
|
|
US5824307A
(en)
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
FR2686901A1
(fr)
|
1992-01-31 |
1993-08-06 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides antithrombotiques, leur preparation et compositions pharmaceutiques les contenant.
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
WO1993019197A1
(en)
|
1992-03-20 |
1993-09-30 |
Immunet |
Human monoclonal antibodies and methods for human monoclonal antibody production
|
|
GB9207479D0
(en)
|
1992-04-06 |
1992-05-20 |
Scotgen Ltd |
Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
|
|
US6685942B1
(en)
|
1993-12-10 |
2004-02-03 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
CA2144043C
(en)
*
|
1992-09-16 |
2005-01-18 |
Dennis R. Burton |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
WO1994015640A1
(en)
|
1993-01-12 |
1994-07-21 |
Anthony George Gristina |
Methods and compositions for the direct concentrated delivery of passive immunity
|
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
|
US5424189A
(en)
|
1993-03-05 |
1995-06-13 |
Kansas State University Research Foundation |
Bovine respiratory syncytial virus detection and primers
|
|
RU2160119C2
(ru)
*
|
1993-05-25 |
2000-12-10 |
Американ Цианамид Компани |
Вакцинная композиция, содержащая белок респираторно-синцитиального вируса (варианты)
|
|
WO1994029351A2
(en)
|
1993-06-16 |
1994-12-22 |
Celltech Limited |
Antibodies
|
|
EP0724602A4
(en)
|
1993-07-30 |
1998-12-23 |
Oravax Inc |
MONOCLONAL IgA ANTIBODIES AGAINST RESPIRATORY SYNCYTIAL VIRUS
|
|
US5506209A
(en)
|
1994-05-26 |
1996-04-09 |
Abbott Laboratories |
Product for inhibition of infection of mammalian cells by respiratory syncytial virus
|
|
US5538952A
(en)
|
1994-05-26 |
1996-07-23 |
Abbott Laboratories |
Inhibition of infection of mammalian cells by respiratory syncytial virus
|
|
US5538733A
(en)
|
1994-07-07 |
1996-07-23 |
Willmar Poultry Company, Inc. |
Method of priming an immune response in a one-day old animal
|
|
US5792456A
(en)
|
1994-08-04 |
1998-08-11 |
Bristol-Myers Squibb Company |
Mutant BR96 antibodies reactive with human carcinomas
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
AU4755696A
(en)
|
1995-01-05 |
1996-07-24 |
Board Of Regents Acting For And On Behalf Of The University Of Michigan, The |
Surface-modified nanoparticles and method of making and using same
|
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5811524A
(en)
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
EP0850051A2
(en)
|
1995-08-31 |
1998-07-01 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
|
DE69609188T2
(de)
|
1995-09-18 |
2000-12-21 |
Intracel Corp., Issaquah |
Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
|
|
ATE508733T1
(de)
|
1996-03-04 |
2011-05-15 |
Penn State Res Found |
Materialien und verfahren zur steigerung der zellulären internalisierung
|
|
WO1997034631A1
(en)
|
1996-03-18 |
1997-09-25 |
Board Of Regents, The University Of Texas System |
Immunoglobin-like domains with increased half lives
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
WO1998023289A1
(en)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
MODULATION OF IgG BINDING TO FcRn
|
|
FR2758331B1
(fr)
|
1997-01-14 |
1999-03-05 |
Univ Bourgogne |
Nouveaux moyens pour le diagnostic, la prevention et le traitement vis-a-vis de contaminations ou d'infections par des virus a tropisme muqueux
|
|
ES2236832T3
(es)
|
1997-01-16 |
2005-07-16 |
Massachusetts Institute Of Technology |
Preparacion de particulas para inhalacion.
|
|
US6590079B2
(en)
|
1997-01-30 |
2003-07-08 |
Ixsys, Incorporated |
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
|
|
EP0971696B1
(en)
|
1997-02-06 |
2010-06-09 |
Merck Sharp & Dohme Corp. |
Thimerosal-free preservatives for vaccines
|
|
US6117980A
(en)
|
1997-02-21 |
2000-09-12 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
|
EP1025230B1
(en)
|
1997-12-01 |
2006-02-08 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE
|
|
CA2323757C
(en)
|
1998-04-02 |
2011-08-02 |
Genentech, Inc. |
Antibody variants and fragments thereof
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
WO1999066903A2
(en)
|
1998-06-24 |
1999-12-29 |
Advanced Inhalation Research, Inc. |
Large porous particles emitted from an inhaler
|
|
US6572856B1
(en)
|
1998-09-10 |
2003-06-03 |
The University Of Virginia Patent Foundation |
Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
|
|
ATE384792T1
(de)
|
1998-11-18 |
2008-02-15 |
Genentech Inc |
Antikörpervarianten mit höheren bindungsaffinitäten im vergleich zu parentalen antikörpern
|
|
US7553487B2
(en)
*
|
1998-12-14 |
2009-06-30 |
Genetics Institute, Llc |
Method and compositions for treating asthma
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
HUP0104865A3
(en)
|
1999-01-15 |
2004-07-28 |
Genentech Inc |
Polypeptide variants with altered effector function
|
|
AR022952A1
(es)
|
1999-03-19 |
2002-09-04 |
Smithkline Beecham Corp |
ANTICUERPO MONOCLONAL DE ROEDOR ESPECIFICAMENTE NEUTRALIZANTE PARA LA INTERLEUQUINA-18 HUMANA , UN FRAGMENTO FAB NEUTRALIZANTE o FRAGMENTO F(AB')2, UNA REGION DE COMPLEMENTARIEDAD DE CADENA LIGERA DE INMONOGLOBULINA(CDR), UNA MOLECULA DE ACIDO NUCLEICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE, EL
|
|
US7090973B1
(en)
*
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
|
AR030019A1
(es)
*
|
1999-05-18 |
2003-08-13 |
Smithkline Beecham Corp |
Anticuerpos monoclonales humanos y fragmentos funcionales del mismo, un procedimiento para su produccion, composiciones farmaceuticas que los comprenden, una molecula aislada de acido nucleico, un plasmido recombinante, una celula hospedante y el uso de dichos anticuerpos para la manufactura de un m
|
|
WO2000073346A1
(en)
|
1999-05-27 |
2000-12-07 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Immunoconjugates having high binding affinity
|
|
WO2001064751A2
(en)
|
2000-03-01 |
2001-09-07 |
Medimmune, Inc. |
High potency recombinant antibodies and method for producing them
|
|
DK1265928T3
(da)
|
2000-01-27 |
2010-11-15 |
Medimmune Llc |
RSV-neutraliserende antistoffer med ultra høj affinitet
|
|
US7229619B1
(en)
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US20010034062A1
(en)
|
2000-02-09 |
2001-10-25 |
Scott Koenig |
Antibody gene therapy with adeno-associated viral vectors
|
|
CA2399832C
(en)
|
2000-02-11 |
2011-09-20 |
Stephen D. Gillies |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
AU2001241918A1
(en)
|
2000-03-02 |
2001-09-12 |
Med Immune, Inc. |
Methods of enhancing activity of vaccines and vaccine compositions
|
|
EP1278767A4
(en)
|
2000-04-12 |
2003-11-12 |
Principia Pharmaceutical Corp |
ALBUMIN FUSED PROTEINS
|
|
EP2264072A1
(en)
|
2000-04-13 |
2010-12-22 |
The Rockefeller University |
Enhancement of antibody-mediated cytotoxicity.
|
|
ATE457177T1
(de)
|
2000-05-03 |
2010-02-15 |
Medimmune Llc |
Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
|
|
EP1152199B1
(de)
|
2000-05-03 |
2005-07-27 |
IPV Inheidener Produktions- und Vertriebsgesellschaft mbH |
Thermobehälter
|
|
AU2001259379B2
(en)
|
2000-05-03 |
2006-08-03 |
Medimmune, Llc |
Combination therapy of respiratory diseases using antibodies
|
|
WO2001089562A1
(en)
|
2000-05-25 |
2001-11-29 |
Medimmune, Inc. |
F-protein epitope-based vaccine for respiratory syncytial virus infection
|
|
EP1336410A4
(en)
|
2000-08-04 |
2005-10-12 |
Chugai Pharmaceutical Co Ltd |
PROTEIN INJECTION PREPARATIONS
|
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
|
WO2002030984A1
(en)
*
|
2000-10-13 |
2002-04-18 |
Uab Research Foundation |
Human anti-epidermal growth factor receptor single-chain antibodies
|
|
US6818216B2
(en)
*
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
JP4434580B2
(ja)
|
2000-11-28 |
2010-03-17 |
メディミューン，エルエルシー |
予防及び治療のために抗ｒｓｖ抗体を投与／処方する方法
|
|
US7179900B2
(en)
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
PT1355919E
(pt)
|
2000-12-12 |
2011-03-02 |
Medimmune Llc |
Moléculas com semivida longa, composições que as contêm e suas utilizações
|
|
US7658921B2
(en)
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
EP1381631B1
(en)
|
2001-04-24 |
2010-10-13 |
Bayer Corporation |
Human anti timp-1 antibodies
|
|
AR039067A1
(es)
*
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
|
ATE555194T1
(de)
*
|
2001-12-18 |
2012-05-15 |
Cancer Rec Tech Ltd |
Methode zur herstellung von proliferierenden und differenzierenden zelllinien
|
|
US6911321B2
(en)
|
2001-12-19 |
2005-06-28 |
Genentech, Inc. |
Non-human primate Fc receptors and methods of use
|
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
|
DE60328195D1
(de)
|
2002-03-29 |
2009-08-13 |
Schering Corp |
Menschliche monoklonale antikörper gegen interleukin-5 sowie diese umfassende verfahren und zusammensetzungen
|
|
WO2003102136A2
(en)
*
|
2002-05-30 |
2003-12-11 |
Human Genome Sciences, Inc. |
Antibodies that specifically bind to neurokinin b
|
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
US7425618B2
(en)
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
JP4660189B2
(ja)
|
2002-07-03 |
2011-03-30 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
抗血小板自己抗体およびそのインヒビターに関連する組成物、方法およびキット
|
|
TW200501985A
(en)
|
2002-07-25 |
2005-01-16 |
Medimmune Inc |
Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
|
|
AU2003262650B2
(en)
|
2002-08-14 |
2009-10-29 |
Macrogenics, Inc. |
FcgammaRIIB-specific antibodies and methods of use thereof
|
|
CA2832136C
(en)
|
2002-09-27 |
2015-11-17 |
Xencor |
Optimized fc variants and methods for their generation
|
|
US20040110930A1
(en)
|
2002-10-03 |
2004-06-10 |
Reinl Stephen J. |
Multimeric protein engineering
|
|
JP4768439B2
(ja)
|
2002-10-15 |
2011-09-07 |
アボット バイオセラピューティクス コーポレイション |
変異誘発による抗体のＦｃＲｎ結合親和力又は血清半減期の改変
|
|
WO2004043989A2
(en)
|
2002-11-07 |
2004-05-27 |
Medarex, Inc. |
Human monoclonal antibodies to heparanase
|
|
US7696334B1
(en)
*
|
2002-12-05 |
2010-04-13 |
Rosetta Genomics, Ltd. |
Bioinformatically detectable human herpesvirus 5 regulatory gene
|
|
GB0306618D0
(en)
|
2003-03-22 |
2003-04-30 |
Univ Newcastle |
Antibody
|
|
AU2005214988A1
(en)
|
2004-02-17 |
2005-09-01 |
Absalus, Inc. |
Super-humanized antibodies against respiratory syncytial virus
|
|
US7700720B2
(en)
|
2004-09-21 |
2010-04-20 |
Medimmune, Llc |
Antibodies against and methods for producing vaccines for respiratory syncytial virus
|
|
EP1807111A4
(en)
|
2004-10-08 |
2009-05-27 |
Abbott Biotech Ltd |
SYNCYTIAL RESPIRATORY VIRUS INFECTION (RSV)
|
|
AU2005302453A1
(en)
|
2004-10-29 |
2006-05-11 |
Medimmune, Llc |
Methods of preventing and treating RSV infections and related conditions
|
|
US7423128B2
(en)
*
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
|
ATE492563T1
(de)
|
2004-11-17 |
2011-01-15 |
Amgen Inc |
Vollständige humane monoklonale antikörper gegen il-13
|
|
AU2005318171B2
(en)
|
2004-12-20 |
2011-09-29 |
Crucell Holland B.V. |
Binding molecules capable of neutralizing West Nile virus and uses thereof
|
|
EP2284194A1
(en)
|
2004-12-21 |
2011-02-16 |
AstraZeneca AB |
Antibodies directed to angiopoietin-2 and uses thereof
|
|
EP1877075A4
(en)
|
2005-04-25 |
2008-07-30 |
Pfizer |
ANTIBODY TO MYOSTATIN
|
|
US20070110757A1
(en)
|
2005-06-23 |
2007-05-17 |
Ziping Wei |
Antibody formulations having optimized aggregation and fragmentation profiles
|
|
ES2660899T3
(es)
*
|
2005-12-09 |
2018-03-26 |
Academisch Medisch Centrum Bij De Universiteit Van Amsterdam |
Medios y métodos para influir en la estabilidad de las células productoras de anticuerpos
|
|
AR056857A1
(es)
*
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
EP1997830A1
(en)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV specific binding molecules and means for producing them
|
|
CA2688667A1
(en)
|
2007-06-26 |
2008-12-31 |
Medimmune, Llc |
Methods of treating rsv infections and related conditions
|
|
BRPI0817079A2
(pt)
|
2007-09-07 |
2016-10-11 |
Symphogen As |
processos para fabricação recombinante de anticorpos anti-rsv
|
|
WO2009114815A1
(en)
|
2008-03-13 |
2009-09-17 |
Dyax Corp |
Libraries of genetic packages comprising novel hc cdr3 designs
|
|
CA2776249C
(en)
|
2009-10-06 |
2021-01-19 |
Medimmune Ltd |
Rsv-specific binding molecule
|
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
|
DK2950886T3
(da)
|
2013-02-01 |
2020-03-23 |
Medimmune Llc |
Respiratorisk syncytialvirus-f-protein-epitoper
|
|
US20160340414A1
(en)
|
2014-01-15 |
2016-11-24 |
Medimmune, Llc |
Rsv-specific antibodies and functional parts thereof
|